- Home
- CVAC vs RCAT Comparison
CVAC vs RCAT Comparison
Compare CVAC & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- RCAT
- Stock Information
- Founded
- CVAC 2000
- RCAT 2002
- Country
- CVAC Germany
- RCAT United States
- Employees
- CVAC N/A
- RCAT N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- RCAT Wholesale Distributors
- Sector
- CVAC Health Care
- RCAT Industrials
- Exchange
- CVAC Nasdaq
- RCAT Nasdaq
- Market Cap
- CVAC 818.8M
- RCAT 850.5M
- IPO Year
- CVAC 2020
- RCAT 2017
- Fundamental
- Price
- CVAC $3.30
- RCAT $7.76
- Analyst Decision
- CVAC Hold
- RCAT Strong Buy
- Analyst Count
- CVAC 3
- RCAT 1
- Target Price
- CVAC $10.00
- RCAT $4.00
- AVG Volume (30 Days)
- CVAC 617.5K
- RCAT 7.7M
- Earning Date
- CVAC 11-12-2024
- RCAT 03-17-2025
- Dividend Yield
- CVAC N/A
- RCAT N/A
- EPS Growth
- CVAC N/A
- RCAT N/A
- EPS
- CVAC N/A
- RCAT N/A
- Revenue
- CVAC $70,565,734.00
- RCAT $16,468,647.00
- Revenue This Year
- CVAC $742.57
- RCAT $113.68
- Revenue Next Year
- CVAC N/A
- RCAT $206.40
- P/E Ratio
- CVAC N/A
- RCAT N/A
- Revenue Growth
- CVAC 75.11
- RCAT 95.46
- 52 Week Low
- CVAC $2.22
- RCAT $0.69
- 52 Week High
- CVAC $5.28
- RCAT $15.27
- Technical
- Relative Strength Index (RSI)
- CVAC 39.12
- RCAT 38.28
- Support Level
- CVAC $3.53
- RCAT $8.60
- Resistance Level
- CVAC $3.72
- RCAT $9.69
- Average True Range (ATR)
- CVAC 0.18
- RCAT 0.92
- MACD
- CVAC -0.06
- RCAT -0.17
- Stochastic Oscillator
- CVAC 10.96
- RCAT 0.72
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.